(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL was host to an excellent, thought-provoking presentation by Dr. Jean Hoffman-Censits, MD, discussing whether there is evidence to justify extrapolating the benefit of neoadjuvant chemotherapy from bladder cancer to upper tract urothelial carcinoma (UTUC).
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL hosted a debate regarding the role of pelvic lymph node dissection (PLND) in prostate cancer presented by Dr. Karim A. Touijer, MD, MPH who had the unenviable task of advocating both for and against this procedure.
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL hosted an overview of emergent biomarkers to identify patients with high-risk non-metastatic renal cell carcinoma (RCC) presented by Dr. Brandon Manley, MD. Dr. Manley began his talk by discussing methylation profiles in clear cell RCC (ccRCC). Wei et al. used genome-wide CpG methylation […]
(UroToday.com) The Society of Urologic Oncology (SUO) annual winter meeting included a health services research session and a presentation by Dr. Anobel Odisho discussing clinical informatic strategies to accelerate research in urologic oncology.
(UroToday.com) The Society of Urologic Oncology (SUO) annual winter meeting included a health services research session and a presentation by Dr. Jill Hamilton-Reeves discussing digital innovations to improve perioperative bladder cancer care. Dr. Hamilton-Reeves notes that the promise of digital innovation is that it (i) reduces inefficiencies, (ii) extends support and accountability, (iii) strengthens communication […]
(UroToday.com) The Society of Urologic Oncology (SUO) annual winter meeting included an advanced prostate cancer session and a presentation by Dr. Kelvin Moses discussing financial and toxicity considerations when managing advanced prostate cancer.
(UroToday.com) The Society of Urologic Oncology (SUO) annual winter meeting included an advanced prostate cancer session and a presentation by Dr. Ale Berlin discussing metastasis-directed therapy for oligorecurrent prostate cancer. Dr. Berlin started with a clinical case example of a 71 year-old-male with a diagnosis of unfavorable intermediate risk prostate cancer who underwent a radical prostatectomy […]
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL hosted a second State of the Art Lecture by Dr. Robert Dreicer, MD, MS, MACP, FASCO discussing adjuvant therapy for kidney cancer.
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL was host to an excellent overview by Dr. Maria Carlo, MD of the future of genomic evaluation to direct therapy in renal cell carcinoma (RCC). Dr. Carlo began her presentation by defining genomic biomarkers in cancer as: “A measurable DNA or RNA characteristic […]
(UroToday.com) The Society of Urologic Oncology (SUO) 2021 annual meeting in Orlando, FL was host to an excellent presentation by Dr. Katie S. Murray, DO, MS, FACS regarding intraluminal therapy for upper tract urothelial carcinoma (UTUC).
